載入...
Dual TLR2 and TLR7 agonists as HIV latency-reversing agents
The presence of a reservoir of latently infected cells in HIV-infected patients is a major barrier towards finding a cure. One active cure strategy is to find latency-reversing agents that induce viral reactivation, thus leading to immune cell recognition and elimination of latently infected cells,...
Na minha lista:
| 發表在: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Clinical Investigation
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6237480/ https://ncbi.nlm.nih.gov/pubmed/30282829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.122673 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|